NO893062L - Anvendelse av isokinolinforbindelser, saerlig i inhalasjonspreparater. - Google Patents

Anvendelse av isokinolinforbindelser, saerlig i inhalasjonspreparater.

Info

Publication number
NO893062L
NO893062L NO89893062A NO893062A NO893062L NO 893062 L NO893062 L NO 893062L NO 89893062 A NO89893062 A NO 89893062A NO 893062 A NO893062 A NO 893062A NO 893062 L NO893062 L NO 893062L
Authority
NO
Norway
Prior art keywords
isokinolic
compounds
specifically
inhalation preparations
inhalation
Prior art date
Application number
NO89893062A
Other languages
English (en)
Other versions
NO177485C (no
NO893062D0 (no
NO177485B (no
Inventor
William Joseph Houlihan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO893062D0 publication Critical patent/NO893062D0/no
Publication of NO893062L publication Critical patent/NO893062L/no
Publication of NO177485B publication Critical patent/NO177485B/no
Publication of NO177485C publication Critical patent/NO177485C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO893062A 1988-07-29 1989-07-27 Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat NO177485C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22630588A 1988-07-29 1988-07-29
US07/302,720 US4910206A (en) 1986-07-14 1989-01-27 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Publications (4)

Publication Number Publication Date
NO893062D0 NO893062D0 (no) 1989-07-27
NO893062L true NO893062L (no) 1990-01-30
NO177485B NO177485B (no) 1995-06-19
NO177485C NO177485C (no) 1995-09-27

Family

ID=26920416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893062A NO177485C (no) 1988-07-29 1989-07-27 Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat

Country Status (16)

Country Link
US (1) US4910206A (no)
EP (1) EP0357550B1 (no)
JP (1) JPH0273016A (no)
KR (1) KR910002445A (no)
AU (1) AU632487B2 (no)
CA (1) CA1336503C (no)
DE (1) DE68913397T2 (no)
DK (1) DK372089A (no)
ES (1) ES2062092T3 (no)
FI (1) FI893616A (no)
HU (1) HU206040B (no)
IE (1) IE63243B1 (no)
IL (1) IL91128A (no)
NO (1) NO177485C (no)
NZ (1) NZ230098A (no)
PT (1) PT91302B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE84724T1 (de) * 1988-04-27 1993-02-15 Schering Corp Gewisse paf-antagonist/antihistamin-mischungen und verfahren.
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
JPH08502243A (ja) 1992-07-13 1996-03-12 サイトメッド,インコーポレイテッド 炎症性および免疫性疾患の治療のための2,5‐ジアリールテトラヒドロ‐チオフェン、‐フランおよび類似体
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
FR2756560A1 (fr) * 1996-12-04 1998-06-05 Adir Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1076728C (zh) * 1999-02-05 2001-12-26 浙江大学 2-芳基咪唑并[2,1-a]异喹啉的衍生物及其用途
CN112574176B (zh) * 2019-09-27 2024-03-15 隆泰申医药科技(南京)有限公司 一种杂芳基类化合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4101553A (en) * 1974-01-02 1978-07-18 Sandoz, Inc. Imidazo[2,1-a]isoquinolines
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
HU206114B (en) * 1986-07-14 1992-08-28 Sandoz Ag Process for producing 5-hetero- or aryl-substituted imidazo(2,1-a)iso-quinoline derivatives and pharmaceutical compositions comprising same as active ingredient

Also Published As

Publication number Publication date
EP0357550B1 (en) 1994-03-02
CA1336503C (en) 1995-08-01
AU632487B2 (en) 1993-01-07
DE68913397T2 (de) 1994-08-11
DK372089D0 (da) 1989-07-27
EP0357550A3 (en) 1991-04-03
PT91302A (pt) 1990-02-08
DE68913397D1 (de) 1994-04-07
IE63243B1 (en) 1995-04-05
FI893616A (fi) 1990-01-30
ES2062092T3 (es) 1994-12-16
NO177485C (no) 1995-09-27
NO893062D0 (no) 1989-07-27
IL91128A0 (en) 1990-03-19
US4910206A (en) 1990-03-20
IL91128A (en) 1996-01-31
EP0357550A2 (en) 1990-03-07
HUT50630A (en) 1990-03-28
HU206040B (en) 1992-08-28
FI893616A0 (fi) 1989-07-28
PT91302B (pt) 1995-03-01
NZ230098A (en) 1992-02-25
JPH0273016A (ja) 1990-03-13
AU3901789A (en) 1990-02-01
NO177485B (no) 1995-06-19
KR910002445A (ko) 1991-02-25
IE892459L (en) 1990-01-29
DK372089A (da) 1990-01-30

Similar Documents

Publication Publication Date Title
NL300038I2 (nl) Thiazolidinedionderivaten, alsmede bereiding en toepassing daarvan.
NO880626L (no) Fenol-stabiliserte mikrobiocidpreparater.
NO875045D0 (no) Fremgangsmaate for fremstilling av topiske preparater for behandling av akne.
FI873010A0 (fi) Nitrofuranderivat, deras framstaellning och deras terapeutiska tillaempning.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO893062L (no) Anvendelse av isokinolinforbindelser, saerlig i inhalasjonspreparater.
FI884048A (fi) Foerfarande foer bestaemning av halten av en gaskomponent i en patients andningsluft.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO163486C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater.
FI860209A (fi) Engaongselektrod foer undersoekning av en patient.
IT8548385A0 (it) Composti maftalenici,loro preparazi one e loro impiego come medicamenti
NO893143D0 (no) Fremstilling av klordioksyd.
DE58903514D1 (de) Derivate der 2,3-difluorbenzoesaeure.
NO863343L (no) Fremgangsmaate for fremstilling av gem-dihalo-1,8-diamino-4-aza-octaner.
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
NO911243L (no) Kjemiske preparater.
NO891706L (no) Fremgangsmaate for fremstilling av cyklodekstrinkomplekserav 5-aminoheksahydropyrimidinforbindelser.
NO904108D0 (no) Fremstilling av 2,6-dioksypiperidinderivater.
FI860049A (fi) Mikro-organismer av slaektet hyphomicrobium och foerfarande foer nedbrytning av metylgrupphaltiga foereningar, speciellt metylgrupphaltiga fosforfoereningar i vattenhaltiga loesningar.
NO863045D0 (no) Fremgangsmaate for fremstilling av alkyl-2-karboalkoksy-3,4-dialkoksybenzenkarbamater.
NO864305D0 (no) Fremgangsmaate for fremstilling av 5-nafthyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO861178L (no) Fremgangsmaate for fremstilling av 1,8-nafthyridinoner.
FI864736A0 (fi) Foerfarande foer framstaellning av 2-substituerade 5-nitroso-4,6-diamino-pyrimidiner.